These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23026825)

  • 1. Dickkopf-1 and hepatocellular carcinoma.
    Tsai JF; Jeng JE; Chuang WL
    Lancet Oncol; 2012 Oct; 13(10):e410; author reply e410-1. PubMed ID: 23026825
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers for early diagnosis of hepatocellular carcinoma.
    Forner A; Bruix J
    Lancet Oncol; 2012 Aug; 13(8):750-1. PubMed ID: 22738800
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma.
    Ge T; Shen Q; Wang N; Zhang Y; Ge Z; Chu W; Lv X; Zhao F; Zhao W; Fan J; Qin W
    Med Oncol; 2015 Mar; 32(3):59. PubMed ID: 25652109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma.
    Kim SU; Park JH; Kim HS; Lee JM; Lee HG; Kim H; Choi SH; Baek S; Kim BK; Park JY; Kim DY; Ahn SH; Lee JD; Han KH
    Yonsei Med J; 2015 Sep; 56(5):1296-306. PubMed ID: 26256972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
    PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of DKK1 and AFP improves diagnostic accuracy of hepatocellular carcinoma compared with either marker alone.
    Erdal H; Gül Utku Ö; Karatay E; Çelik B; Elbeg Ş; Doğan İ
    Turk J Gastroenterol; 2016 Jul; 27(4):375-81. PubMed ID: 27458854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.
    Vongsuvanh R; van der Poorten D; Iseli T; Strasser SI; McCaughan GW; George J
    PLoS One; 2016; 11(5):e0155800. PubMed ID: 27219517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma.
    Fatima S; Luk JM; Poon RT; Lee NP
    Expert Rev Mol Diagn; 2014 Jun; 14(5):535-48. PubMed ID: 24809435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour markers of hepatocellular carcinoma.
    Kew MC
    J Gastroenterol Hepatol; 1989; 4(4):373-84. PubMed ID: 2562350
    [No Abstract]   [Full Text] [Related]  

  • 10. Considerations in the significance of Dickkopf-1 levels in human hepatocellular carcinoma.
    Cai G; Yin W
    Liver Int; 2012 Oct; 32(9):1460; author reply 1460-1. PubMed ID: 22276962
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma.
    Van Hees S; Michielsen P; Vanwolleghem T
    World J Gastroenterol; 2016 Oct; 22(37):8271-8282. PubMed ID: 27729734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on "Profiling serologic biomarkers in cirrhotic patients via high-throughput Fourier transform infrared spectroscopy: toward a new diagnostic tool of hepatocellular carcinoma".
    Lewis PD
    Transl Res; 2013 Nov; 162(5):275-8. PubMed ID: 24035850
    [No Abstract]   [Full Text] [Related]  

  • 13. Dickkopf-1: as a diagnostic and prognostic serum marker for early hepatocellular carcinoma.
    Yang H; Chen GD; Fang F; Liu Z; Lau SH; Zhang JF; Lau WY; Yang LY
    Int J Biol Markers; 2013 Sep; 28(3):286-97. PubMed ID: 23568769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. γ-Glutamyl transferase and its role as a biomarker of systemic malignancies other than hepatocellular carcinomas.
    Kapoor S
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):387. PubMed ID: 23348021
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum tests for diagnosis and follow-up of hepatocellular carcinoma after treatment.
    Trojan J; Raedle J; Zeuzem S
    Digestion; 1998 Jul; 59 Suppl 2():72-4. PubMed ID: 9718428
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
    Giannini EG; Farinati F; Trevisani F
    Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475
    [No Abstract]   [Full Text] [Related]  

  • 17. Candidate biomarkers for liver cancer.
    Cottingham K
    J Proteome Res; 2009 Feb; 8(2):428. PubMed ID: 19271311
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of serum CA125 in patients with hepatocellular carcinoma].
    Ohgi N; Horie Y; Maeda N; Hirayama C
    Nihon Shokakibyo Gakkai Zasshi; 1988 Oct; 85(10):2239-42. PubMed ID: 2850378
    [No Abstract]   [Full Text] [Related]  

  • 19. Sensitivity and specificity of Dickkopf-1 protein in serum for diagnosing hepatocellular carcinoma: a meta-analysis.
    Zhang J; Zhao Y; Yang Q
    Int J Biol Markers; 2014 Dec; 29(4):e403-10. PubMed ID: 24980448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma tumour markers: current role and expectations.
    Rich N; Singal AG
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):843-53. PubMed ID: 25260312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.